RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting apoptosis
RAF1 mediates anlotinib resistance in NSCLC cells by regulating apoptosis and may serve as a predictive marker for anlotinib resistance in advanced lung cancer patients.
Authors
- Xiaodong Jiang (ORCID: https://orcid.org/0000-0002-9656-4972)
- Shuo Wu (ORCID: https://orcid.org/0000-0002-2908-6595)
- Chenxi Hu (ORCID: https://orcid.org/0000-0002-8397-9319)
- Wei He (ORCID: https://orcid.org/0000-0002-9553-2055)
- Kaiyuan Hui
Institutions
- Xuzhou Medical College (CN)
- Lianyungang Oriental Hospital (CN)
- The First People’s Hospital of Lianyungang (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1007/s00432-025-06175-0
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.05